• Kyodo


As Japan prepares to begin COVID-19 vaccinations this week, dry ice manufacturers are racing to ensure they can meet the expected surge in demand driven by a need to store the Pfizer Inc. vaccine at an ultracold temperature.

But preparations, critical for a smooth vaccine rollout, are facing challenges, with dry ice-makers possibly unable to ramp up production capacity quickly enough partly due to the difficulty of acquiring enough liquid carbon dioxide to create the refrigerant.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.